ASBP
Aspire Biopharma·NASDAQ
--
--(--)
--
--(--)
ASBP Filings
Filing Date
Form Description
Form Type
2026-02-24
Form DEF 14A - Other definitive proxy statements
Key Events
2026-02-24 · Key Events
Form DEF 14A - Other definitive proxy statements
2026-02-17
Form S-1 - General form for registration of securities under the Securities Act of 1933
2026-02-17 ·
Form S-1 - General form for registration of securities under the Securities Act of 1933
2026-02-12
Form PRE 14A - Other preliminary proxy statements
Key Events
2026-02-12 · Key Events
Form PRE 14A - Other preliminary proxy statements
2026-02-12
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026-02-12 ·
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026-02-12
Form 8-K - Current report
Key Events
2026-02-12 · Key Events
Form 8-K - Current report
2026-02-06
Form 8-K - Current report
Key Events
2026-02-06 · Key Events
Form 8-K - Current report
2026-01-30
Form 8-K - Current report
Key Events
2026-01-30 · Key Events
Form 8-K - Current report
2026-01-15
Form 8-K - Current report
Key Events
2026-01-15 · Key Events
Form 8-K - Current report
2026-01-13
Form 8-K - Current report
Key Events
2026-01-13 · Key Events
Form 8-K - Current report
2026-01-06
Form 8-K - Current report
Key Events
2026-01-06 · Key Events
Form 8-K - Current report
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
